State Street’s Protagonist Therapeutics PTGX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $177M | Buy |
|
|||||
|
2025
Q1 | $131M | Sell |
|
|||||
|
2024
Q4 | $129M | Buy |
|
|||||
|
2024
Q3 | $143M | Buy |
|
|||||
|
2024
Q2 | $72.2M | Sell |
|
|||||
|
2024
Q1 | $94.7M | Buy |
|
|||||
|
2023
Q4 | $62.6M | Sell |
|
|||||
|
2023
Q3 | $65.8M | Buy |
|
|||||
|
2023
Q2 | $98.1M | Buy |
|
|||||
|
2023
Q1 | $55.5M | Sell |
|
|||||
|
2022
Q4 | $41.4M | Sell |
|
|||||
|
2022
Q3 | $39.4M | Sell |
|
|||||
|
2022
Q2 | $53.6M | Buy |
|
|||||
|
2022
Q1 | $77.1M | Buy |
|
|||||
|
2021
Q4 | $87.9M | Buy |
|
|||||
|
2021
Q3 | $35.7M | Buy |
|
|||||
|
2021
Q2 | $65.3M | Sell |
|
|||||
|
2021
Q1 | $44.4M | Buy |
|
|||||
|
2020
Q4 | $29.9M | Buy |
|
|||||
|
2020
Q3 | $22.6M | Buy |
|
|||||
|
2020
Q2 | $6.76M | Buy |
|
|||||
|
2020
Q1 | $2.24M | Sell |
|
|||||
|
2019
Q4 | $2.38M | Buy |
|
|||||
|
2019
Q3 | $3.78M | Buy |
|
|||||
|
2019
Q2 | $3.18M | Buy |
|
|||||
|
2019
Q1 | $177K | Sell |
|
|||||
|
2018
Q4 | $96K | Sell |
|
|||||
|
2018
Q3 | $151K | Buy |
|
|||||
|
2018
Q2 | $96K | Sell |
|
|||||
|
2018
Q1 | $1.31M | Buy |
|
|||||
|
2017
Q4 | $2.85M | Buy |
|
|||||
|
2017
Q3 | $2.07M | Buy |
|
|||||
|
2017
Q2 | $1.27M | Buy |
|
|||||
|
2017
Q1 | $1.19M | Buy |
|
|||||
|
2016
Q4 | $2.03M | Buy |
|
|||||
|
2016
Q3 | $1.29M | Buy |
|